Literature DB >> 25391708

Emergency and critical care management of acute ischaemic stroke.

Stephen A Figueroa1, Weidan Zhao, Venkatesh Aiyagari.   

Abstract

Ischaemic stroke is a devastating condition that is the leading cause of disability in the USA. Over the last 2 decades, the focus of management has shifted from secondary stroke prevention to acute treatment. Coordinated care starts in the field with the emergency medical service providers and continues in the ambulance and the emergency department through to the intensive care unit. After diagnosis and stabilization, a major goal is reperfusion therapy with intravenous fibrinolytics. Neuroimaging research is focused on improving patient selection, expanding treatment windows, and increasing the safety of therapeutic intervention. The role of adjunctive intra-arterial and mechanical thrombectomy remains undefined, and methods to improve reperfusion using sonolysis and new-generation fibrinolytics are currently investigational. Treatment in the intensive care unit targets prevention of secondary brain injury through optimization of blood pressure, cerebral perfusion, glucose, and temperature management, ventilation, and oxygenation. The most feared complications include malignant cerebral edema and symptomatic hemorrhagic transformation. Decompressive craniectomy is life saving, but questions regarding patient selection and timing remain. Hyperosmolar agents are currently used to mitigate cerebral edema, but newer agents to prevent the formation of cerebral edema at the molecular level are being studied. We outline a practical approach to current emergency and intensive care management based on consensus guidelines and the best available evidence.

Entities:  

Mesh:

Year:  2015        PMID: 25391708     DOI: 10.1007/s40263-014-0210-2

Source DB:  PubMed          Journal:  CNS Drugs        ISSN: 1172-7047            Impact factor:   5.749


  85 in total

1.  Validation of a new coma scale: The FOUR score.

Authors:  Eelco F M Wijdicks; William R Bamlet; Boby V Maramattom; Edward M Manno; Robyn L McClelland
Journal:  Ann Neurol       Date:  2005-10       Impact factor: 10.422

2.  Blood pressure and clinical outcomes in the International Stroke Trial.

Authors:  Jo Leonardi-Bee; Philip M W Bath; Stephen J Phillips; Peter A G Sandercock
Journal:  Stroke       Date:  2002-05       Impact factor: 7.914

3.  Time is brain--quantified.

Authors:  Jeffrey L Saver
Journal:  Stroke       Date:  2005-12-08       Impact factor: 7.914

4.  Controlling hypertension and hypotension immediately post-stroke (CHHIPS): a randomised, placebo-controlled, double-blind pilot trial.

Authors:  John F Potter; Thompson G Robinson; Gary A Ford; Amit Mistri; Martin James; Julia Chernova; Carol Jagger
Journal:  Lancet Neurol       Date:  2008-12-04       Impact factor: 44.182

5.  Unsuspected coagulopathy rarely prevents IV thrombolysis in acute ischemic stroke.

Authors:  N S Rost; S Masrur; M A Pervez; A Viswanathan; L H Schwamm
Journal:  Neurology       Date:  2009-11-25       Impact factor: 9.910

6.  A trial of imaging selection and endovascular treatment for ischemic stroke.

Authors:  Chelsea S Kidwell; Reza Jahan; Jeffrey Gornbein; Jeffry R Alger; Val Nenov; Zahra Ajani; Lei Feng; Brett C Meyer; Scott Olson; Lee H Schwamm; Albert J Yoo; Randolph S Marshall; Philip M Meyers; Dileep R Yavagal; Max Wintermark; Judy Guzy; Sidney Starkman; Jeffrey L Saver
Journal:  N Engl J Med       Date:  2013-02-08       Impact factor: 91.245

Review 7.  Management of hypertension in acute stroke.

Authors:  Venkatesh Aiyagari; Aamir Badruddin
Journal:  Expert Rev Cardiovasc Ther       Date:  2009-06

8.  Newly expressed SUR1-regulated NC(Ca-ATP) channel mediates cerebral edema after ischemic stroke.

Authors:  J Marc Simard; Mingkui Chen; Kirill V Tarasov; Sergei Bhatta; Svetlana Ivanova; Ludmila Melnitchenko; Natalya Tsymbalyuk; G Alexander West; Volodymyr Gerzanich
Journal:  Nat Med       Date:  2006-03-19       Impact factor: 53.440

9.  Effect of thrombolysis with alteplase within 6 h of acute ischaemic stroke on long-term outcomes (the third International Stroke Trial [IST-3]): 18-month follow-up of a randomised controlled trial.

Authors: 
Journal:  Lancet Neurol       Date:  2013-06-21       Impact factor: 44.182

10.  EuroHYP-1: European multicenter, randomized, phase III clinical trial of therapeutic hypothermia plus best medical treatment vs. best medical treatment alone for acute ischemic stroke.

Authors:  H Bart van der Worp; Malcolm R Macleod; Philip M W Bath; Jacques Demotes; Isabelle Durand-Zaleski; Bernd Gebhardt; Christian Gluud; Rainer Kollmar; Derk W Krieger; Kennedy R Lees; Carlos Molina; Joan Montaner; Risto O Roine; Jesper Petersson; Dimitre Staykov; Istvan Szabo; Joanna M Wardlaw; Stefan Schwab
Journal:  Int J Stroke       Date:  2014-05-15       Impact factor: 5.266

View more
  1 in total

1.  Therapeutic time window for conivaptan treatment against stroke-evoked brain edema and blood-brain barrier disruption in mice.

Authors:  Emil Zeynalov; Susan M Jones; J Paul Elliott
Journal:  PLoS One       Date:  2017-08-30       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.